SCHEMBL20049459

SCHEMBL20049459

CSc1cc(C2CC2)c2nc(C)sc2c1

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.35
CHRNA4 P43681 1/20 0.35
MAPT P10636 3/20 0.33
NPC1 O15118 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALOX15 P16050 1/20 0.33
ATM Q13315 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
HSD17B10 Q99714 1/20 0.33
GAA P10253 1/20 0.32
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20049390 0.81 CHRNB2 (0.39) CHRNB2CHRNA4MAPTNPC1SMN1; SMN2
SCHEMBL21098334 0.78 CHRNB2 (0.37) CHRNB2CHRNA4MAPTNPC1SMN1; SMN2
SCHEMBL21098342 0.76 CHRNB2 (0.35) CHRNB2CHRNA4MAPTNPC1SMN1; SMN2
SCHEMBL21097746 0.76 CHRNB2 (0.35) CHRNB2CHRNA4MAPTNPC1SMN1; SMN2
SCHEMBL22255018 0.74 ALDH1A1 (0.39) MAPTNPC1SMN1; SMN2ALOX15ATM
SCHEMBL22672609 0.74 NPC1 (0.47) CHRNB2CHRNA4MAPTNPC1SMN1; SMN2
SCHEMBL22672659 0.69 NPC1 (0.44) CHRNB2CHRNA4MAPTNPC1SMN1; SMN2
SCHEMBL22672583 0.69 NPC1 (0.44) CHRNB2CHRNA4MAPTNPC1SMN1; SMN2
SCHEMBL16615785 0.64 SMN1; SMN2 (0.58) MAPTNPC1SMN1; SMN2ALOX15ATM
SCHEMBL18587304 0.62 CHRNB2 (0.54) CHRNB2CHRNA4MAPTNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018067704-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. (US) 2018-04-12 WO disclosed